The Effect of Neuraxial Morphine (Duramorph) on Pain Control
Launched by AUGUSTA UNIVERSITY · Apr 23, 2019
Trial Information
Current as of June 19, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients with a second degree, third degree, or fourth degree perineal tear identified in the immediate postpartum period.
- • Pregnant patients who received neuraxial anesthesia during their labor course
- • Women \>18 yo
- Exclusion Criteria:
- • Unwillingness to participate in the study
- • Allergy to morphine
- • Women with history of polysubstance abuse/narcotic abuse
- • Women \<18 yo
About Augusta University
Augusta University is a prominent academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a leader in medical education and patient care, Augusta University conducts rigorous clinical studies aimed at improving treatment outcomes and enhancing patient quality of life. The university’s commitment to interdisciplinary collaboration fosters a dynamic research environment, enabling the exploration of novel therapies and interventions across a wide range of medical fields. With a focus on ethical standards and patient safety, Augusta University strives to translate scientific discoveries into tangible benefits for the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
N. Augusta, South Carolina, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials